Publication date: Aug 06, 2019
A recent study by Polyzos et al. (Cell Metab., 2019) shows that astrocytes in a Huntington disease (HD) mouse model switch from glycolysis to fatty acid oxidation (FAO), causing increased superoxide radical anion production and loss of succinate dehydrogenase (SD) activity. Blocking mitochondria reactive oxygen species (ROS) with an antioxidant compound called XJB-5-151 reversed lipofuscin formation and protected the mice.
Van Houten, B. Huntington’s Disease: Astrocytes Shift to Fatty Acid Metabolism. 06623. 2019 Trends Endocrinol Metab.
|pathway||BSID||Fatty acid oxidation|
|pathway||BSID||Fatty acid metabolism|
- Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington’s Disease.